IC
AEGR

ISZO Capital’s Aegerion Pharmaceuticals AEGR Stock Holding History

ISZO Capital’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$2.35M Buy
+33,150
New +$2.53M 1.74% 6

Other funds holding AEGR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ISZO Capital's AEGR Position: Q4 2013 in Review

ISZO Capital opened a new position in Aegerion Pharmaceuticals (AEGR) in Q4 2013: 33,150 shares worth $2.35M. The stake represents 1.74% of the portfolio and ranks #6 among its holdings.

150 funds tracked by Wall St. Rank hold AEGR as of Q4 2013.

  • ISZO Capital held 33,150 shares of Aegerion Pharmaceuticals worth $2.35M as of Q4 2013.
  • Aegerion Pharmaceuticals was a new ISZO Capital position in Q4 2013.
  • Aegerion Pharmaceuticals made up 1.74% of ISZO Capital's portfolio in Q4 2013, its #6 holding.
  • 150 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2013.

Based on ISZO Capital's 13F filing for Q4 2013, filed 14 Feb 2014.